Hemule GmbH

Hemule was launched in 2015 by an experienced group of scientists and engineers to pave the way for human-on-the-chip revolution. Using our innovative H-chip technology, we aim to transform the way the safety and effectiveness of new drugs are evaluated. We provide both services and products to the life sciences, pharmacological and cosmetics industries. Our model is collaborative - we work closely with our partners to leverage and expand their in-house capabilities.